[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that three-year survival data from the Phase 1b C-800-01 study

Maison Solutions Inc. Class A Common Stock (MSS) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q3
the company's inability to maintain positive net income, which reached -$5.2 million in 2026Q3, alongside a precarious current ratio of 0.67, suggests a high risk of insolvency.
Maison Solutions Inc. Class A Common Stock (MSS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Recent stock market news and headlines for Maison Solutions Inc. Class A Common Stock (MSS)
[url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that three-year survival data from the Phase 1b C-800-01 study

Key metrics vs top competitors for Maison Solutions Inc. Class A Common Stock (MSS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.60 | $1.26M | 0.91 | 114.01% | 0.94% | 10.46% | — | |
| $33.74 | $777.4M | 16.87 | 7.19% | 3.6% | 22.26% | — | |
| $42.08 | $623.17M | 11.02 | 3.76% | 2.27% | 10.74% | — | |
| $98.21 | $4B | 58.46 | 9.36% | 1.87% | 13.54% | — | |
| $115.50 | $18.14B | 52.98 | 8.61% | 0.49% | 7.13% | — | |
| $84.09 | $7.91B | 15.84 | 14.08% | 5.7% | 36.06% | — |
Maison Solutions Inc. Class A Common Stock (MSS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Maison Solutions Inc. Class A Common Stock (MSS) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 6, 2026·SEC
Jul 6, 2026·SEC
Jun 9, 2026·SEC
Aug 14, 2025·SEC
Get notified when MSS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Maison Solutions Inc. Class A Common Stock (MSS) stock FAQ — growth, dividends, profitability & financials explained
Maison Solutions Inc. Class A Common Stock (MSS) reported $113.7M in revenue for fiscal year 2025. This represents a 176% increase from $41.2M in 2021.
Maison Solutions Inc. Class A Common Stock (MSS) grew revenue by 114.0% over the past year. This is strong growth.
Maison Solutions Inc. Class A Common Stock (MSS) reported a net loss of $12.0M for fiscal year 2025.
Maison Solutions Inc. Class A Common Stock (MSS) has a return on equity (ROE) of 10.5%. This is reasonable for most industries.
Maison Solutions Inc. Class A Common Stock (MSS) had negative free cash flow of $0.7M in fiscal year 2025, likely due to heavy capital investments.